Member Info for crumbs

'“The feedback that we have received from Genmab on the anti-glycan monoclonal antibody is that they liked the specifics of the candidate,” Lindy Durrant, Scancell CEO, told BioWorld. “For example, strong tumor staining and limited expression on normal tissues. They also liked the good internalization of the candidate showing the potential for delivery of antibody-drug conjugate.”

This is far from the first agreement between the two companies. In January 2001, Genmab and then-privately held Scancell began a collaboration to create a fully human antibody for targeting the Lewisy/b antigen, which is overexpressed in breast, lung, colon and ovarian cancers.'

A long association!

It's not like he doesn't have his own dreams

US grants $350 mln for Malawi projects, hailing good governance

https://www.breitbart.com/news/us-grants-350-mln-for-malawi-projects-hailing-good-governance/

:)) £8 worth of cardboard at 6p a sheet....

As for valuations I also said yesterday I see this as we should now have a £200 million mcap... don't think that is rampy but realistic and on nailing another/s MaB deals that ought to then multiply especially is those involve big names...

I think the reason for bouncey sp is the upfront payment ... not knowing the amount and when it arrives for instance if the market knew scancell will have $30 million going into the bank next week... well that would be highly reassuring lol...

I trust the upfront is heading our way soon and though doubt is £30 million (plucked that out for ramp effect obs) could well be $10 million but certainly from having to rely on only investment cash to getting actual payment from deals cash is fantastic considering another 4 MaB deals might be on their way ....SeaGen seemingly a possible

Good for the Linkedin bios lol

Obviously, there is going to be an RNS of a BOD recruitment coming soon too and likely that will be a 'bigger name' than the one now moving on.... which means in fundamental terms today's announcement is just formality as the company progresses from a research spinout into a proper biotech with trials and deals

A prediction! We will not see £8 this year! lol .... And Haribos will be back in before years end and back out and back in

£8 was actually Innanco long ago and became a running theme on here... like I say yes I believe if all the pieces fit £8 and not just £8 is very possible here but that depends on those pieces coming together.... not sure what you are now banging on about or why? .... This is still a risk share but after yesterday a lot less risky,,, is that rampy? ...

And one thing is for certain data is incoming on Covidity including AvidiMab data on SCIB1 CI combo and data on the modify modi1 mega trial..... Time your ins and outs for all that and deals on 4 more MaBs potential AvidiMab licensing deals too

Yup that is saying if we get humanised mouse data coming in for modi 1 .... we can expect absolute fireworks... that is an 'if' though and we may not get that kind of data might be from rubbish to ok to great.... to humanised mouse or better!

risk reward mate....meanwhile other pieces are in play and the MABs are being commercialised so all good!

nice of you to bring up the £8 though :)) ....

Looks like Haribos is looking for his next in.... the £8 prediction is an infamous running theme on here which I did not start and have never stated it will happen last year or next year but that scancells IP could indeed realize such returns and beyond if all the pieces come together... first MAB commercial deal piece now in place... moditope data reflecting humanised mouse data would be the one to see this to £8 and beyond but still many pieces in play...

Be nice to see you back in for the ride :)

Market, in general, is clueless about scancell so yes probably takes today's RNS as a negative which it is not... also lots of 10%ers yesterday who pile in without a clue and pile out too some probably at a loss now duh... but those who know know :) .... crumbsy nibbles when it goes below me average the more you have and all that :) .... Also I'm sure some serious investors who overlooked scancell until it did a commercial deal will now be getting interested so... sp action will as ever be fun to witness

Is teasing!

Yes, I'll miss RG more too and who the heck is going to run the Twitter now lol!.... I propose you Berm :)

We'll not know till we know I mean he is carrying on for now which means its all very amicable I didn't mind him but he rubbed a lot up with his AGM performances, especially on Q&A, fact is at the time he came in and brought in CH we needed them! And was probably not attracting anything better.... now though I'd like to think we may be in for more of a name coming in as it were ...

They'll be quite a few not too unhappy to see Chippers move on it now means that the whole era of him and his man CH is over.... The question is who now comes in but certainly after yesterday's news this company is moving up and is far more investable in, to those whose adversity to very high risk appetite would have previously put them off ....

Well RG I think yeah we all knew as he was temporary Chippers it does say personal reasons and he has given a nice little positive goodbye speech there.....So... what I will say is probably Redmile has a say in who may be coming in

Of a whole new Scancell ...Thanks to Chippers and especially RG he go the deal in the end! :)

https://malawi24.com/2022/10/17/unima-students-tour-rare-earths-project-in-phalombe/